Supplemental material
Expert Review of Vaccines
Volume 18, 2019 - Issue 6
Open access
6,507
Views
23
CrossRef citations to date
0
Altmetric
Review
Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation
Ron DaganThe Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, IsraelCorrespondence[email protected]
https://orcid.org/0000-0002-8888-1046View further author information
Pages 641-661
|
Received 14 Feb 2019, Accepted 31 May 2019, Published online: 22 Jun 2019
Related Research Data
The immunogenicity and impact on nasopharyngeal carriage of fewer doses of conjugate pneumococcal vaccine immunization schedule
Source:
Elsevier BV
Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine
Source:
Springer Science and Business Media LLC
Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings.
Source:
Ovid Technologies (Wolters Kluwer Health)
The 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Coadministered With DTPw-HBV/Hib and Poliovirus Vaccines: Assessment of Immunogenicity
Source:
Ovid Technologies (Wolters Kluwer Health)
Impact of 13-Valent Pneumococcal Conjugate Vaccination on Streptococcus pneumoniae Carriage in Young Children in Massachusetts
Source:
Oxford University Press (OUP)
Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program.
Source:
Public Library of Science (PLoS)
Early Trends for Invasive Pneumococcal Infections in Children After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine
Source:
Ovid Technologies (Wolters Kluwer Health)
Response to Primary and Booster Vaccination With 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine in Korean Infants
Source:
Ovid Technologies (Wolters Kluwer Health)
Invasive pneumococcal disease burden in Hong Kong children.
Source:
Ovid Technologies (Wolters Kluwer Health)
Changes in Invasive Pneumococcal Disease among HIV-Infected Adults Living in the Era of Childhood Pneumococcal Immunization
Source:
American College of Physicians
Differences in the epidemiology of invasive pneumococcal disease, metropolitan NSW, 1997?2001
Source:
The Sax Institute
OUP accepted manuscript
Source:
Oxford University Press (OUP)
Direct and Indirect Effects of PCV13 on Nasopharyngeal Carriage of PCV13 Unique Pneumococcal Serotypes in Massachusetts’ Children
Source:
Ovid Technologies (Wolters Kluwer Health)
Pneumococcal vaccine impact on otitis media microbiology: A New Zealand cohort study before and after the introduction of PHiD-CV10 vaccine
Source:
Elsevier BV
Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006).
Source:
Elsevier BV
Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation
Source:
Taylor & Francis
Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants.
Source:
Elsevier BV
Discovery of a New Capsular Serotype (6C) within Serogroup 6 of Streptococcus pneumoniae
Source:
American Society for Microbiology
Serum Serotype‐Specific Pneumococcal Anticapsular Immunoglobulin G Concentrations after Immunization with a 9‐Valent Conjugate Pneumococcal Vaccine Correlate with Nasopharyngeal Acquisition of Pneumococcus
Source:
Oxford University Press (OUP)
The rise and fall of pneumococcal serotypes carried in the PCV era
Source:
Elsevier BV
Post HocAnalysis of a Randomized Double-Blind Trial of the Correlation of Functional and Binding Antibody Responses Elicited by 13-Valent and 7-Valent Pneumococcal Conjugate Vaccines and Association with Nasopharyngeal Colonization
Source:
American Society for Microbiology
Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-ResistantStreptococcus pneumoniae
Source:
New England Journal of Medicine (NEJM/MMS)
Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England
Source:
Elsevier BV
Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands
Source:
Centers for Disease Control and Prevention (CDC)
Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children
Source:
Oxford University Press (OUP)
Carriage ofStreptococcus pneumoniae3 Years after Start of Vaccination Program, the Netherlands
Source:
Centers for Disease Control and Prevention (CDC)
Impact of the Conjugation Method on the Immunogenicity ofStreptococcus pneumoniaeSerotype 19F Polysaccharide in Conjugate Vaccines
Source:
American Society for Microbiology
Nasopharyngeal Pneumococcal Carriage after Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Children with a History of Recurrent Acute Otitis Media
Source:
Oxford University Press (OUP)
Occurrence, Distribution, and Origins of Streptococcus pneumoniae Serotype 6C, a Recently Recognized Serotype
Source:
American Society for Microbiology
The fundamental link between pneumococcal carriage and disease
Source:
Informa UK Limited
Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid.
Source:
Elsevier BV
Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial
Source:
Elsevier BV
Carriage ofStreptococcus pneumoniae3 Years after Start of Vaccination Program, the Netherlands
Source:
Centers for Disease Control and Prevention (CDC)
Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumococcal carriage in Fiji: results from four annual cross-sectional carriage surveys
Source:
Elsevier BV
Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers.
Source:
Oxford University Press (OUP)
Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada.
Source:
Elsevier BV
Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study
Source:
Elsevier BV
Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D–Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media—A Double-Blind Randomized Clinical Trial in Finland
Source:
Oxford University Press (OUP)
Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies
Source:
Elsevier BV
Vaccines and Vaccination
Source:
Elsevier
Comparative Immunogenicity and Efficacy of 13-Valent and 7-Valent Pneumococcal Conjugate Vaccines in Reducing Nasopharyngeal Colonization: A Randomized Double-Blind Trial
Source:
Oxford University Press (OUP)
Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers
Source:
American Academy of Pediatrics (AAP)
Temporal Trends and Molecular Epidemiology of Recently Described Serotype 6C of Streptococcus pneumoniae
Source:
American Society for Microbiology
Streptococcus pneumoniae serotype 19A: worldwide epidemiology
Source:
Informa UK Limited
Impact of Ten-Valent Pneumococcal Conjugate Vaccine Introduction on Serotype Distribution Trends in Colombia: An Interrupted Time-Series Analysis
Source:
Oxford University Press (OUP)
Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
Source:
Ovid Technologies (Wolters Kluwer Health)
Safety, Tolerability and Immunogenicity of 15-valent Pneumococcal Conjugate Vaccine in Toddlers Previously Vaccinated With 7-valent Pneumococcal Conjugate Vaccine
Source:
Ovid Technologies (Wolters Kluwer Health)
Vaccines and Vaccination
Source:
Elsevier
Differential Effects of Pneumococcal Vaccines against Serotypes 6A and 6C
Source:
Oxford University Press (OUP)
A 13-year survey of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 and PCV13 implementation
Source:
Elsevier BV
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
Source:
Ovid Technologies (Wolters Kluwer Health)
Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage.
Source:
Ovid Technologies (Wolters Kluwer Health)
Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study
Source:
Elsevier BV
Molecular surveillance of nasopharyngeal carriage of Streptococcus pneumoniae in children vaccinated with conjugated polysaccharide pneumococcal vaccines
Source:
Springer Nature
Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway
Source:
Elsevier BV
Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel
Source:
Informa UK Limited
The Role of Antibody and Complement in the Reticuloendothelial Clearance of Pneumococci from the Bloodstream
Source:
Oxford University Press (OUP)
Serotype replacement in disease after pneumococcal vaccination
Source:
Elsevier BV
A Trial of a 9-Valent Pneumococcal Conjugate Vaccine in Children with and Those without HIV Infection
Source:
New England Journal of Medicine (NEJM/MMS)
Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation
Source:
Taylor & Francis
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates
Source:
Elsevier BV
Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
Source:
Oxford University Press (OUP)
Effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae among children in São Paulo, Brazil.
Source:
Elsevier BV
Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia
Source:
Ovid Technologies (Wolters Kluwer Health)
Polysaccharide-Specific Memory B Cells Predict Protection against Experimental Human Pneumococcal Carriage
Source:
American Thoracic Society
Concentration of Antipneumococcal Antibodies as a Serological Correlate of Protection: An Application to Acute Otitis Media
Source:
Oxford University Press (OUP)
Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012
Source:
Canadian Science Publishing
Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines.
Source:
Ovid Technologies (Wolters Kluwer Health)
Effects of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugate Vaccine on Nasopharyngeal Bacterial Colonization in Young Children: A Randomized Controlled Trial
Source:
Oxford University Press (OUP)
Bactericidal Antibody Persistence 2 Years After Immunization With 2 Investigational Serogroup B Meningococcal Vaccines at 6, 8 and 12 Months and Immunogenicity of Preschool Booster Doses
Source:
Ovid Technologies (Wolters Kluwer Health)
The Contribution of Specific Pneumococcal Serogroups to Different Disease Manifestations: Implications for Conjugate Vaccine Formulation and Use, Part II
Source:
Oxford University Press (OUP)
Impact of 13-Valent Pneumococcal Conjugate Vaccination in Invasive Pneumococcal Disease Incidence and Mortality
Source:
Oxford University Press (OUP)
Effect on nasopharyngeal pneumococcal carriage of replacing PCV7 with PCV13 in the Expanded Programme of Immunization in The Gambia
Source:
Elsevier BV
Pneumococcal vaccination: Direct and herd effect on carriage of vaccine types and antibiotic resistance in Icelandic children
Source:
Elsevier BV
Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) When Coadministered With Different Neisseria meningitidis Serogroup C Conjugate Vaccines
Source:
Ovid Technologies (Wolters Kluwer Health)
Effect of Reduced-Dose Schedules With 7-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Pneumococcal Carriage in Children
Source:
American Medical Association (AMA)
Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the Netherlands.
Source:
The Authors. Published by Elsevier Ltd.
Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study
Source:
Elsevier BV
Immunogenicity and Safety of a 13-Valent Pneumococcal Conjugate Vaccine Given With DTaP Vaccine in Healthy Infants in Japan
Source:
Ovid Technologies (Wolters Kluwer Health)
Increase in the Prevalence of the Newly Discovered Pneumococcal Serotype 6C in the Nasopharynx after Introduction of Pneumococcal Conjugate Vaccine
Source:
Oxford University Press (OUP)
Direct Effect of 10-Valent Conjugate Pneumococcal Vaccination on Pneumococcal Carriage in Children Brazil
Source:
Public Library of Science (PLoS)
Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants
Source:
Public Library of Science (PLoS)
Pneumococcal vaccine and opsonic pneumococcal antibody.
Source:
Elsevier BV
CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization
Source:
Proceedings of the National Academy of Sciences
Impact of Conjugate Vaccine on Transmission of Antimicrobial-Resistant Streptococcus pneumoniae Among Alaskan Children
Source:
Ovid Technologies (Wolters Kluwer Health)
Multinational study of pneumococcal serotypes causing acute otitis media in children.
Source:
Ovid Technologies (Wolters Kluwer Health)
Modeling pneumococcal nasopharyngeal acquisition as a function of anticapsular serum antibody concentrations after pneumococcal conjugate vaccine administration
Source:
Elsevier BV
Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation
Source:
Taylor & Francis
Effects of Vaccination on Invasive Pneumococcal Disease in South Africa
Source:
New England Journal of Medicine (NEJM/MMS)
Incidence of Community-Acquired Pneumonia in the Population of Four Municipalities in Eastern Finland
Source:
Oxford University Press (OUP)
Predictors of pneumococcal carriage and the effect of the 13-valent pneumococcal conjugate vaccination in the Western Australian Aboriginal population
Source:
Springer Nature
Streptococcus pneumoniae colonisation: the key to pneumococcal disease.
Source:
Elsevier BV
Incidence of Pneumococcal Disease Due to Non-Pneumococcal Conjugate Vaccine (PCV7) Serotypes in the United States during the Era of Widespread PCV7 Vaccination, 1998–2004
Source:
Oxford University Press (OUP)
Herd protection induced by pneumococcal conjugate vaccine
Source:
Elsevier BV
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.